132 related articles for article (PubMed ID: 36797128)
21. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Surgical Management of Advanced Stages of Borderline Ovarian Tumours].
Raimond E; Bourdel N
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):304-313. PubMed ID: 32004785
[TBL] [Abstract][Full Text] [Related]
22. Prise en charge chirurgicale du cancer épithélial de l'ovaire - première ligne et première rechute: Surgical management of epithelial ovarian cancer - first line and first relapse.
Classe JM; Joly F; Lécuru F; Morice P; Pomel C; Selle F; You B
Bull Cancer; 2021 Dec; 108(9S1):S13-S21. PubMed ID: 34955158
[TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of celiac lymph node involvement in patients after frontline treatment for advanced ovarian cancer.
Angeles MA; Ferron G; Cabarrou B; Balague G; Martínez-Gómez C; Gladieff L; Pomel C; Martinez A
Eur J Surg Oncol; 2019 Aug; 45(8):1410-1416. PubMed ID: 30857876
[TBL] [Abstract][Full Text] [Related]
24. Impact of geography and travel distance on outcomes in epithelial ovarian cancer: a national cancer database analysis.
Daruvala A; Lucas FL; Sammon J; Darus C; Bradford L
Int J Gynecol Cancer; 2021 Feb; 31(2):209-214. PubMed ID: 33214215
[TBL] [Abstract][Full Text] [Related]
25. Overall Survival Following Neoadjuvant Chemotherapy vs Primary Cytoreductive Surgery in Women With Epithelial Ovarian Cancer: Analysis of the National Cancer Database.
Rauh-Hain JA; Melamed A; Wright A; Gockley A; Clemmer JT; Schorge JO; Del Carmen MG; Keating NL
JAMA Oncol; 2017 Jan; 3(1):76-82. PubMed ID: 27892998
[TBL] [Abstract][Full Text] [Related]
26. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Stage III Epithelial Ovarian Cancer.
Lei Z; Wang Y; Wang J; Wang K; Tian J; Zhao Y; Chen L; Wang J; Luo J; Jia M; Tang H; He Q; Liao Q; Yang X; Guan T; Wang L; Cui S;
JAMA Netw Open; 2020 Aug; 3(8):e2013940. PubMed ID: 32840622
[TBL] [Abstract][Full Text] [Related]
28. The relationship between neuraxial anesthesia and advanced ovarian cancer-related outcomes in the Chilean population.
Lacassie HJ; Cartagena J; Brañes J; Assel M; Echevarría GC
Anesth Analg; 2013 Sep; 117(3):653-660. PubMed ID: 23868889
[TBL] [Abstract][Full Text] [Related]
29. Surgical outcomes and national comprehensive cancer network compliance in advanced ovarian cancer surgery in a low volume military treatment facility.
Phippen NT; Barnett JC; Lowery WJ; Miller CR; Leath CA
Gynecol Oncol; 2013 Oct; 131(1):158-62. PubMed ID: 23872110
[TBL] [Abstract][Full Text] [Related]
30. [Real-world data analysis of 3012 patients undergoing laparoscopic radical gastrectomy in a single center over the past 12 years].
Wang LJ; Li Z; Wang S; Liu HD; Li QY; Li BW; Xu JH; Ge H; Wang WZ; Li FY; He ZY; Zhang DC; Xu H; Yang L; Xu ZK
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Aug; 25(8):716-725. PubMed ID: 35970806
[No Abstract] [Full Text] [Related]
31. Post-operative pancreatic fistula following splenectomy with or without distal pancreatectomy at cytoreductive surgery in advanced ovarian cancer.
Bizzarri N; Korompelis P; Ghirardi V; O'Donnell RL; Rundle S; Naik R
Int J Gynecol Cancer; 2020 Jul; 30(7):1043-1051. PubMed ID: 32546641
[TBL] [Abstract][Full Text] [Related]
32. [Chirurgie des cancers de l'ovaire].
Azaïs H; Koual M; Bentivegna E; Bats AS
Rev Prat; 2022 Jun; 72(6):627-631. PubMed ID: 35899662
[TBL] [Abstract][Full Text] [Related]
33. A Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy in Primary Advanced Ovarian Cancer: The First Reported Pilot Experience from Saudi Arabia.
Abu-Zaid A; Alomar O; Alsabban M; Salem H; Al-Badawi IA
Gulf J Oncolog; 2020 Sep; 1(34):19-25. PubMed ID: 33431358
[TBL] [Abstract][Full Text] [Related]
34. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO).
du Bois A; Reuss A; Pujade-Lauraine E; Harter P; Ray-Coquard I; Pfisterer J
Cancer; 2009 Mar; 115(6):1234-44. PubMed ID: 19189349
[TBL] [Abstract][Full Text] [Related]
35. Impact of pattern of recurrence on post-relapse survival according to surgical timing in patients with advanced ovarian cancer.
Angeles MA; Spagnolo E; Cabarrou B; Pérez-Benavente A; Gil Moreno A; Guyon F; Rychlik A; Migliorelli F; Bataillon G; Navarro AS; Betrian S; Ferron G; Hernández A; Martinez A
Int J Gynecol Cancer; 2023 Jan; 33(1):50-56. PubMed ID: 36446410
[TBL] [Abstract][Full Text] [Related]
36. [Interest in intestinal resection for treatment of advanced ovarian cancer].
Hamid D; Rohr S; Baldauf JJ; Ritter J; Kurtz E; Dufour P; Meyer P; Minetti A; Meyer C
Ann Chir; 2002 Jan; 127(1):40-7. PubMed ID: 11833305
[TBL] [Abstract][Full Text] [Related]
37. Advanced low grade serous ovarian cancer: A retrospective analysis of surgical and chemotherapeutic management in two high volume oncological centers.
Di Lorenzo P; Conteduca V; Scarpi E; Adorni M; Multinu F; Garbi A; Betella I; Grassi T; Bianchi T; Di Martino G; Amadori A; Maniglio P; Strada I; Carinelli S; Jaconi M; Aletti G; Zanagnolo V; Maggioni A; Savelli L; De Giorgi U; Landoni F; Colombo N; Fruscio R
Front Oncol; 2022; 12():970918. PubMed ID: 36237308
[TBL] [Abstract][Full Text] [Related]
38. Adrenalectomy Risk Score: An Original Preoperative Surgical Scoring System to Reduce Mortality and Morbidity After Adrenalectomy.
Caiazzo R; Marciniak C; Lenne X; Clément G; Theis D; Ménégaux F; Sebag F; Brunaud L; Lifante JC; Mirallie E; Bruandet A; Pattou F;
Ann Surg; 2019 Nov; 270(5):813-819. PubMed ID: 31592809
[TBL] [Abstract][Full Text] [Related]
39. Who is dying after nephrectomy for cancer? Study of risk factors and causes of death after analyzing morbidity and mortality reviews (UroCCR-33 study).
Fontenil A; Bigot P; Bernhard JC; Beauval JB; Soulié M; Charles T; Larre S; Salomon L; Azzouzi R; Méjean A; Bensalah K;
Prog Urol; 2019 Apr; 29(5):282-287. PubMed ID: 30962141
[TBL] [Abstract][Full Text] [Related]
40. [Perioperative care of epithelial ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
Lemoine A; Lambaudie E; Bonnet F; Leblanc E; Alfonsi P
Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):187-196. PubMed ID: 30686730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]